Targeted Quantitative Proteomics Revealed Arsenite-induced Proteasomal Degradation of RhoB in Fibroblast Cells.

Lok Ming Tam, Ming Huang, Yinsheng Wang
Author Information

Abstract

Arsenic is a toxicant widely present in the environment. Previous epidemiological and animal studies support that Arsenic exposure is associated with elevated incidences of lung and skin cancers. Therefore, it is important to understand the molecular mechanisms through which Arsenite initiates malignant transformation of lung and skin tissues. Ras superfamily of small GTPases assumes a crucial role in many cellular processes including transcription, protein synthesis, and trafficking. In addition, small GTPase signaling is known to be altered in many types of cancer. By employing a multiple-reaction monitoring (MRM)-based targeted proteomic method, we found that the protein level of RhoB was substantially decreased in IMR90 human lung fibroblast cells upon a 12-h exposure to 5 ��M NaAsO. In addition, the protein level of ectopically expressed RhoB was found to decline in a dose-dependent manner upon Arsenite exposure in HEK293T, HeLa, and GM00637 cells as well as that of endogenous RhoB protein in IMR90 cells. Moreover, the Arsenite-elicited down-regulation of RhoB was found to arise from enhanced proteasomal degradation. Taken together, we demonstrated, for the first time, that exposure to Arsenite could attenuate the protein expression of RhoB through proteasomal degradation.

References

  1. Mol Cell Biol. 1995 Dec;15(12):6613-22 [PMID: 8524226]
  2. Nature. 2003 Mar 13;422(6928):198-207 [PMID: 12634793]
  3. Toxicology. 2003 Nov 15;193(1-2):161-9 [PMID: 14599775]
  4. J Expo Sci Environ Epidemiol. 2010 May;20(3):245-54 [PMID: 19401722]
  5. Proteomics. 2012 Apr;12(8):1111-21 [PMID: 22577012]
  6. Toxicol Appl Pharmacol. 2004 Aug 1;198(3):243-52 [PMID: 15276403]
  7. Dis Model Mech. 2017 Nov 1;10(11):1313-1322 [PMID: 28882929]
  8. Small GTPases. 2016 Oct;7(4):207-221 [PMID: 27628050]
  9. Cells. 2019 Mar 16;8(3): [PMID: 30884855]
  10. Environ Health Perspect. 2013 Mar;121(3):295-302 [PMID: 23458756]
  11. Expert Rev Proteomics. 2004 Oct;1(3):317-26 [PMID: 15966828]
  12. Toxicol Lett. 2002 Jul 7;133(1):1-16 [PMID: 12076506]
  13. Cancer Res. 2010 Mar 1;70(5):1981-8 [PMID: 20179202]
  14. Toxicol Appl Pharmacol. 2015 Jul 1;286(1):36-43 [PMID: 25804888]
  15. Pharmacogenomics. 2015 Nov;16(16):1843-62 [PMID: 26555006]
  16. PLoS One. 2012;7(9):e44882 [PMID: 23028658]
  17. Cancer Res. 2017 Oct 15;77(20):5445-5451 [PMID: 28807941]
  18. Environ Health Perspect. 2014 May;122(5):A130-4 [PMID: 24784018]
  19. Cancer Res. 2018 Sep 15;78(18):5431-5445 [PMID: 30072397]
  20. Metallomics. 2009;1(3):222-8 [PMID: 20461219]
  21. Toxicol Appl Pharmacol. 2012 Jun 1;261(2):204-16 [PMID: 22521957]
  22. J Proteome Res. 2015 Feb 6;14(2):967-76 [PMID: 25569337]
  23. J Toxicol. 2011;2011:431287 [PMID: 22174709]
  24. Oncogene. 2017 Jun 8;36(23):3213-3222 [PMID: 27991930]
  25. Mol Cancer. 2013 Mar 19;12:20 [PMID: 23510327]
  26. Biochem Biophys Res Commun. 2007 Jan 5;352(1):188-92 [PMID: 17107663]
  27. J Cell Biol. 2004 Dec 20;167(6):1099-112 [PMID: 15596542]
  28. Ann N Y Acad Sci. 2015 Jan;1335:78-99 [PMID: 24961486]
  29. Cancer Res. 2009 Aug 1;69(15):6092-9 [PMID: 19602596]
  30. Blood. 2011 Jun 16;117(24):6425-37 [PMID: 21422471]
  31. Mol Cell Biol. 2004 Jun;24(12):5565-76 [PMID: 15169915]
  32. Biomed Res Int. 2017;2017:4367019 [PMID: 28913352]
  33. Biol Trace Elem Res. 2016 Mar;170(1):173-82 [PMID: 26231544]
  34. Small GTPases. 2016 Jul 2;7(3):123-38 [PMID: 27104658]
  35. Chem Rev. 2013 Oct 9;113(10):7769-92 [PMID: 23808632]
  36. Small GTPases. 2013 Jul-Sep;4(3):159-63 [PMID: 24088985]
  37. Trends Biochem Sci. 2015 Dec;40(12):765-778 [PMID: 26498262]
  38. Cell. 2000 Jan 7;100(1):57-70 [PMID: 10647931]
  39. Int J Oncol. 2017 Oct;51(4):1025-1034 [PMID: 28848995]
  40. Lung Cancer Manag. 2014 Jan 1;3(1):67-75 [PMID: 25342981]
  41. Development. 2018 Sep 17;145(18): [PMID: 30224385]
  42. Oncogene. 2016 Apr 7;35(14):1760-9 [PMID: 26148238]
  43. Rev Environ Health. 2012 Sep 10;27(4):191-5 [PMID: 22962196]

Grants

  1. R01 ES025121/NIEHS NIH HHS
  2. T32 ES018827/NIEHS NIH HHS

MeSH Term

Arsenites
Cell Line, Tumor
Down-Regulation
Fibroblasts
HEK293 Cells
Humans
Proteasome Endopeptidase Complex
Proteolysis
Proteomics
rhoB GTP-Binding Protein

Chemicals

Arsenites
RHOB protein, human
Proteasome Endopeptidase Complex
rhoB GTP-Binding Protein
arsenite

Word Cloud

Created with Highcharts 10.0.0RhoBproteinexposurelungarsenitefoundcellsskinsmallmanyadditionlevelIMR90uponproteasomaldegradationArsenictoxicantwidelypresentenvironmentPreviousepidemiologicalanimalstudiessupportarsenicassociatedelevatedincidencescancersThereforeimportantunderstandmolecularmechanismsinitiatesmalignanttransformationtissuesRassuperfamilyGTPasesassumescrucialrolecellularprocessesincludingtranscriptionsynthesistraffickingGTPasesignalingknownalteredtypescanceremployingmultiple-reactionmonitoringMRM-basedtargetedproteomicmethodsubstantiallydecreasedhumanfibroblast12-h5��MNaAsOectopicallyexpresseddeclinedose-dependentmannerHEK293THeLaGM00637wellendogenousMoreoverarsenite-eliciteddown-regulationariseenhancedTakentogetherdemonstratedfirsttimeattenuateexpressionTargetedQuantitativeProteomicsRevealedArsenite-inducedProteasomalDegradationFibroblastCells

Similar Articles

Cited By

No available data.